Sterile Fill-Finish

With Curia as your partner, you have access to a wide range of experts in parenteral formulation/process development as well as clinical and commercial sterile manufacturing, providing a complete end-to-end experience to successfully bring your product to market. 

Partnering with Curia

With Curia, you have a customized experience with a dedicated project manager and team of subject matter experts. Curia’s multi-site capabilities approach ensures you have complete ownership and engagement throughout the entire project life cycle.

Contact Us

We are experts in simple and complex formulations and have a proven track record with liquid and lyophilized formulations, in various formats including vials, pre-filled syringes and cartridges.

We operationalize lab scale production that helps mitigate downstream risk. You can trust Curia to execute and deliver an optimal pharmaceutical manufacturing process.

Our Approach is a Process, 
not a Platform

At each product development milestone, you can easily transfer into Curia, to advance and streamline the process.
Our Target Product Profile (TPP) covers:

  • Route of administration
  • Dosage concentration
  • Container closure system
  • Critical Quality Attributes
  • Critical Process Parameters

Curia supports your needs throughout all phases of development

Watch as our experts talk about Curia’s expertise in biologics’ formulation and sterile fill-finish capabilities and how we help to make a difference in people’s lives.

What sets Curia apart:

  • End-to-end development in sterile fill-finish
  • Lyophilization expertise in all phases
  • Formulation and process development support
  • Handling of Controlled drugs (Schedule I to V)
  • Efficient and reliable internal technology transfer process

Contact Us

Our Drug Product Site Network

Discover the power of our drug product network! Save time, cut costs, and seamlessly advance your product with our extensive site network.

Clinical Sterile Fill-Finish Locations

Click each site to see where and whay we offer by location

Camarillo and Thousand Oaks, CA, US
  • Bulk Capacity 0.5 - 100 L
  • GMP Dose Filling Lines Vials, syringes & cartridges
  • Validated For 2 – 30 mL vials 1 – 2.25 mL syringes 1.5 mL cartridges
  • Non-cyto Liquid and Lyophilized
  • Cyto/Highly Potent No
  • Expertise and Capabilities
    • Formulation development (large and small molecule)
    • Analytical Development
    • High concentration formulation technology
    • Lyophilization cycle development and optimization
    • Aseptic processing
    • Microfluidization/high-shear homogenization/extrusion
    • Suspensions/emulsions/liposomal/nanoparticles
    • Small molecule
    • Proteins/peptides/oligonucleotides
    • Monoclonal antibodies (mAbs)
    • Inactivated and attenuated live virus
    • Clinical supply (Pre-clinical – Phase III)
    • Full In-house QC/Microbiology Services
    • Stability Services
  • Quality and Regulatory
    • FDA Registered Facility
Glasgow, UK
  • Bulk Capacity 1 - 100 L
  • GMP Dose Filling Lines Vials
  • Validated For 2 – 50 mL vials
  • Non-cyto Liquid and lyophilized
  • Cyto/Highly Potent Liquid and lyophilized
  • Expertise and Capabilities
    • Formulation development (large and small molecule)
    • Analytical Development
    • Lyophilization cycle development and optimization
    • Aseptic and Terminal Sterilization processes
    • Microfluidization/high-shear homogenization/microfluidics
    • Suspensions/emulsions/liposomal/nanoparticles
    • Small molecule
    • Proteins/peptides/oligonucleotides
    • Monoclonal antibodies (mAbs)/antibody drug conjugates (ADCs)
    • Inactivated and attenuated live virus
    • Clinical supply (Pre-clinical – Phase III)
    • Full in-house QC/Microbiology Services
      Stability Services
  • Quality and Regulatory
    • MHRA licensed
    • QP release
    • Home Office registered for Schedule I – V controlled substances

Commercial Sterile Fill-Finish Locations

Click each site to see where and whay we offer by location

Albuquerque, NM, US
  • Bulk Capacity 1-1200 L
  • GMP Dose Filling Lines Vials, syringes & cartridges
  • Validated For 2 - 100 mL vials 1 - 10 mL syringes
  • Non-cyto Liquid and lyophilized
  • Cyto/Highly Potent Liquid and lyophilized
  • Expertise and Capabilities
    • Microfluidization/high-shear homogenization/extrusion
    • Suspensions/emulsions/liposomal/nanoparticles
    • Small molecule
    • Proteins/peptides/oligonucleotides
    • Monoclonal antibodies (mAbs)
    • Inactivated and attenuated live virus
    • Late phase clinical and commercial
    • Full in-house QC /Microbiology services (including sterility testing)
    • Stability Services
  • Quality and Regulatory
    • FDA and EU Approved
    • DEA registration for Schedule II-V controlled substances
Burlington, MA, US
  • Bulk Capacity 1 - 200 L
  • GMP Dose Filling Lines Vials and syringes
  • Validated For 2 – 50 mL vials 1 – 10 mL syringes
  • Non-cyto Liquid and lyophilized
  • Cyto/Highly Potent Liquid
  • Expertise and Capabilities
    • Process Development
    • Highly viscous formulations
    • Microfluidization/high-shear homogenization/extrusion
    • Suspensions/emulsions/liposomal/nanoparticles
    • Small molecule
    • Proteins/peptides/oligonucleotides
    • Monoclonal antibodies (mAbs)
    • Clinical and commercial
    • In-house QC capabilities
    • Stability Services
  • Quality and Regulatory
    • FDA and EU Approved
    • DEA registration for Schedule II-V controlled substances
Curia is a leader in sterile injectable pharmaceuticals that are produced in vials and syringes for both liquid and lyophilized formulations.

Container Closure Systems 

Vials

  • Pre-validated range from 2 mL to 100 mL
  • Type 1 glass polymer
  • Liquid and lyophilized dosage presentations
  • Lyo capacity range 2mL (~5,000 units – 150,000 units)

Syringes 

  • Small to mid- volume applications
  • Pre-filled syringes in glass (sterile nested) and polymer variants with staked needles/various needle gauges, luer lock/adaptor/cone options

Cartridges 

  • Cylindrical glass barrels suited to devices such as pens, autoinjectors
Contact Us

Injectables

Our expertise lies in highly viscous formulations along with manufacturing complex injectables, liquid nanparticles (LNP), highly potent and cytotoxic compounds, and controlled substances. We embrace complexity.

Lyophilization

Curia’s extensive expertise in the development and optimization of the lyophilization cycle for both small molecule and biologics includes:

  • Stabilization of compounds and selection of lyophilization excipients (CRYO/LYO protecting properties).
  • Thermal properties assessments such as freeze-drying microscopy, Differential Scanning Calorimetry (DSC).
  • Stability assessment of lyophilized and reconstituted solution.

Resources

View All Curia Resources Media
Lyophilization: Protecting and preserving biologics
Learn More
The Benefits of End-to-End Formulation and Fill-Finish of Biologics
Learn More
Leveraging efficiency from cell line development to clinical manufacturing of monoclonal antibodies
Learn More
The current and future value of mRNA vaccines and therapeutics
Learn More
Advancing API development with aseptic manufacturing and processing
Learn More
Curia Enters Cooperative Agreement with U.S. Government to Expand Sterile Fill-Finish Capability
Additional High-Speed Line Adds BSL2 Capacity in the U.S.
Learn More

Connect with an expert

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

Contact a customer service representative:

+1 877-275-2674